MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.280
-0.200 (-5.75%)
At close: Nov 20, 2024, 4:00 PM
3.260
-0.020 (-0.61%)
After-hours: Nov 20, 2024, 7:31 PM EST
MacroGenics Employees
MacroGenics had 339 employees as of December 31, 2023. The number of employees decreased by 18 or -5.04% compared to the previous year.
Employees
339
Change (1Y)
-18
Growth (1Y)
-5.04%
Revenue / Employee
$416,900
Profits / Employee
-$287,956
Market Cap
205.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SOPHiA GENETICS | 430 |
Personalis | 225 |
biote | 194 |
Utah Medical Products | 190 |
Molecular Partners AG | 168 |
Genfit | 159 |
Zentalis Pharmaceuticals | 124 |
Sera Prognostics | 57 |
MGNX News
- 14 days ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results - GlobeNewsWire
- 22 days ago - MacroGenics Announces Leadership Transition - GlobeNewsWire
- 22 days ago - MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 26 days ago - Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders - Accesswire
- 4 weeks ago - MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA® - Business Wire
- 2 months ago - Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX - GlobeNewsWire